Decolonization Kit Regimen for MRSA Resistance and Compliance

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The increasing resistance of bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA), to multiple forms of antibiotics poses a significant risk to human health, especially in hospital settings, with limited effective treatment options available.

Innovation Solution

A specialized decolonization and cleaning kit containing compartments with non-verbal instructions and GUI tools guides users through a timed sequence of antimicrobial components for body and environmental cleaning, including chlorine-based bleach, antimicrobial gels, swabs, probiotics, and probiotic lotions, supported by a smartphone app for monitoring compliance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If multiple forms of antibiotics are used to treat bacterial infections, then the effectiveness of treatment is improved, but bacterial resistance to antibiotics increases

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidbacterial resistance
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent divides the treatment into multiple distinct phases: decolonization phase (eliminating bacteria from body surfaces) and treatment phase (addressing active infections). Different antimicrobial agents with different mechanisms of action are applied in sequence during the decolonization phase, preventing bacteria from developing resistance to a single agent while maintaining treatment effectiveness.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent implements a preliminary decolonization regimen before treating active infections. This preliminary action eliminates or reduces the bacterial load on the patient's body surfaces (skin, nasal passages, etc.), preventing bacteria from developing resistance during the subsequent antibiotic treatment and reducing the risk of transmitting resistant bacteria to other patients.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If antibiotics are administered in hospital settings, then bacterial infections are treated, but patients may acquire dangerous and difficult to treat infections

Engineering Contradiction:
Improveinfection treatmentVSAvoidhospital-associated infections
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent implements a preliminary decolonization regimen before patients are exposed to hospital antibiotics. By eliminating or reducing bacteria from the patient's body surfaces beforehand, the system prevents the acquisition of resistant bacteria during hospitalization and reduces the risk of hospital-associated infections.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses the patient's own bacterial flora as the target for decolonization. By selectively eliminating or reducing the patient's colonizing bacteria (including potential pathogens like MRSA) before hospital treatment, the system converts the potential harm of bacterial colonization into a benefit by preventing future infections and resistance development.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Reliability

If a structured decolonization regimen is implemented, then user compliance is enhanced and bacterial resistance is reduced, but the complexity of the treatment protocol increases

Engineering Contradiction:
Improvedecolonization effectivenessVSAvoidtreatment protocol complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent divides the decolonization regimen into multiple easy-to-follow phases with clear instructions for each. The system provides step-by-step guidance for applying different antimicrobial agents to specific body parts at specific times, making the complex protocol manageable and improving user compliance through structured organization.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent implements a monitoring system that tracks patient compliance with the decolonization regimen and provides feedback to both patients and healthcare providers. This feedback mechanism helps maintain compliance by allowing adjustments to the protocol based on actual usage patterns and effectiveness, reducing the perceived complexity for the patient.

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The kit effectively aids in decolonizing MRSA by providing a structured regimen that enhances user compliance and reduces bacterial resistance, offering a comprehensive approach to infection prevention.

Implementation Method 1

chlorine-based bleach...configured for mixing with a range of volumes of water typically used in an antimicrobial bathing regimen

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 2

By neutralizing that enzyme, β-Lactam antibiotics weaken and break apart the cell wall as water floods the bacteria's cell, in a process called lysis

Methodology Applied
Scientific EffectLysis:

Implementation Method 3

these antibiotics then self-activate (via the activating molecular ring, known as the β-Lactam ring) in the presence of a target enzyme within the bacteria, which enzyme is responsible for building the bacterial cell wall. By neutralizing that enzyme, β-Lactam antibiotics weaken and break apart the cell wall

Methodology Applied
Scientific EffectEnzyme inhibition: Enzyme

Implementation Method 4

Once inside the bacteria, these antibiotics then self-activate (via the activating molecular ring, known as the β-Lactam ring) in the presence of a target enzyme within the bacteria

Methodology Applied
Scientific EffectSelf-activation:

Implementation Method 5

some bacteria generate an enzyme known as β-Lactamase, which breaks the activating (β-Lactam) ring of these antibiotics

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 6

microorganisms capable or recolonizing the micro-biome of the user

Methodology Applied
Scientific EffectMicrobial colonization:

Data Source

PatentUS12535933B2Systems, methods and devices for aiding in the decolonization of bacteria
Publication Date: 2026.01.27 BENUKA HEALTH LLC
  • US12535933B2 patent drawing
  • US12535933B2 patent drawing
  • US12535933B2 patent drawing

AI summary

New systems, methods and devices for aiding in the decolonization of bacterial infections in human and animal patients are provided. In some embodiments, a specialized decolonization, cleaning and infection prevention kit is provided, including a container with compartment(s) that include sub-compartment sections and GUI tools including specialized non-verbal instructions that guide the patient to use combinations of components of the sub-compartments in an infection prevention or decolonization regimen. In some embodiments, each such section provides a variety of decolonization and/or cleaning components for use decolonizing different parts of a user's body and/or environment at particular treatment intervals. In some embodiments, each of the compartment(s) and/or sub-compartment(s) corresponds with an instruction and timing for the use of the components within the compartment or sub-compartment. In some embodiments, a specialized computer system aids in the management of such a regimen, with specialized tracking and coverage-enhancing techniques.